The Semaglutide cohort compared with the Non-GLP-1RA anti-obesity medications cohort was older and had a higher prevalence of morbid obesity, T2D and obesity-associated comorbidities, and a lower prevalence of mental disorders and substance use disorders
Statistical analysis Variables were presented in either numerical form (with means and standard deviations) or categorical form (with counts and percentages), depending on the characteristics of the covariates
"The type of study conducted here helps identify potential links between GLP-1 treatment and NAION, but its not the type of study that can show the treatment caused NAION, states Andrew Lee, MD, a clinical spokesperson for the American Academy of Ophthalmology and a neuro-ophthalmologist at Houston Methodist Hospital, in a recent Vision Monday article
Jameela Address No: 20, Ground Floor, Ramakrishnapurum 2nd Street, Near Adambakkam Police Station, Chennai, Tamil Nadu, 600088, India Report incorrect details
A., Hawley, J